Key result
ADCS/MCI/ADL24 scale outperforms ADL18 in distinguishing aMCI from healthy controls with an ROC of ~0.89.
Why the study?
Does the ADCS/MCI/ADL24 scale improve the ability to distinguish aMCI patients from healthy controls compared to the ADCS/MCI/ADL18 scale in adults aged 60 years or older?
Cross-Sectional (n=94)
Does the ADCS/MCI/ADL24 scale improve the ability to distinguish aMCI patients from healthy controls compared to the ADCS/MCI/ADL18 scale in adults aged 60 years or older?
Answers are grounded in this paper and cite their sources.
The ADCS/MCI/ADL24 scale demonstrates high sensitivity and specificity for distinguishing amnestic mild cognitive impairment from healthy aging, which may aid in early diagnosis and targeted interventions.
Patients with MCI may present minor impairments in activities of daily living (ADL). The main objective of this work was to evaluate the ability of two versions of the Alzheimer's Disease Cooperative Study/Activities of Daily Living scale adapted for MCI patients (ADCS/MCI/ADL18 and ADCS/MCI/ADL24) to distinguish patients with MCI from healthy control subjects. Participants were 60 years or older and community dwelling: 31 control subjects, 30 aMCI patients and 33 AD patients. A protocol of neuropsychological tests, global evaluation scales, functional scales, and depressive symptoms assessment was used. Activities of balancing the cheque book, using a telephone, going shopping, taking medication regularly, finding objects, talking about current events, watching television, initiating complex activities, keeping appointments or meetings, reading, getting around outside the home and driving a car were impaired in aMCI patients. The ADCS/MCI/ADL24 scale was better than the ADCS/MCI/ADL18 scale in distinguishing aMCI patients from healthy controls (sensitivity=0.87, specificity=0.87, ROC c=0.887, cut-off point=52/53). The detection of initial functional changes with appropriate scales may contribute to the early diagnosis of MCI and the development of targeted interventions to improve everyday function or prolong independence.
No takes yet. Share an insight, caveat, or question.
Pedrosa et al. (2010) conducted a cross-sectional in Mild Cognitive Impairment (MCI) (n=94). ADCS/MCI/ADL24 scale vs. ADCS/MCI/ADL18 scale was evaluated on distinguishing aMCI patients from healthy controls (ROC c=0.887). The ADCS/MCI/ADL24 scale effectively distinguished aMCI patients from healthy controls (sensitivity 0.87, specificity 0.87, ROC c=0.887), performing better than the ADCS/MCI/ADL18 scale.
Synapse has enriched 10 related papers. Consider them for comparative context: